Elena V. Kiseleva
Research Subjects
Elena V. Kiseleva has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Andrey Yu. Korolkov
Pavlov University
2 shared publications - Dmitry N. Popov
Pavlov First Saint Petersburg State Medical University
2 shared publications - Larisa A. Logvin
Pavlov University
2 shared publications - Sergey F. Bagnenko
Pavlov First Saint Petersburg State Medical University
2 shared publications - Федор Сергеевич Нефедьев
Pavlov University
2 shared publications - Alexander Anatolyevich Zakharenko
First Pavlov State Medical University of St. Petersburg
1 shared publication
Latest Publications
- Open Access
- 16 September 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in The Scientific Notes of the Pavlov University
- Vol. 32 (2) , 35-43
Treatment and diagnostic algorithm for pregnant women 2–3 trimesters with suspected acute appendicitis
Introduction. Diagnosing the causes of acute abdominal pain in pregnant women is challenging. Due to the absence of ionizing radiation and better visualization of the appendix compared to ultrasound, magnetic resonance imaging is increasingly recommended as an alternative for examining pregnant women with acute abdominal pain. However, in some cases, it is not possible to perform MRI, which limits the use of this method and necessitates stratification of pregnant patients according to the likelihood of adding MRI to the diagnostic complex.The objective was to develop a model for predicting the risk of developing acute appendicitis in pregnant women in the 2nd and 3rd trimesters.Methods and materials. The analysis of data of pregnant patients hospitalized at the Pavlov First Saint Petersburg State Medical University with suspected acute appendicitis was performed from January 2020 to January 2025 (n=94). The study took into account epidemiological, clinical, laboratory, instrumental, surgical and postoperative data. A univariate analysis was performed to predict the presence of acute appendicitis in pregnant women in the 2nd and 3rd trimesters, followed by the construction of a diagnostic model and the identification of risk classes. To confirm the quality of the constructed model, regression analysis was used followed by risk analysis.Results. A model for predicting acute appendicitis in pregnant women in the 2nd–3rd trimesters was constructed based on clinical and laboratory parameters and ultrasound diagnostics with the identification of risk levels (AuRoc 0.84). The patients included in the average risk group underwent MRI to clarify the diagnosis of acute appendicitis and perform differential diagnostics with other pathologies of the abdominal cavity and pelvic organs. The proposed model for predicting acute appendicitis in pregnant women in the 2nd–3rd trimesters using MRI diagnostics in the average risk group has a high predictive quality (AuRoc 0.98) with a sensitivity of 96.9 % and a specificity of 97.6 %.Conclusion. The identified factors (pain in the right lower quadrant of the abdomen, leukocyte level≥12.5·109/l, granulocyte percentage ≥76.4, positive Kocher sign, nausea/vomiting and C-reactive protein level> 6.0 mg/l) can be used to predict acute appendicitis in pregnant women in the 2nd and 3rd trimesters, taking into account the data of instrumental studies (ultrasound and MRI). The constructed model for predicting acute appendicitis, based on clinical and laboratory parameters and ultrasound diagnostics with the identification of risk levels, can be recommended for use in the diagnostics of acute appendicitis in pregnant women in the 2nd and 3rd trimesters. Stratification of pregnant women by the risk level of acute appendicitis allows for the reasonable use of MRI only in the average risk group for the purpose of differential diagnosis of the disease.
- 16 September 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in The Scientific Notes of the Pavlov University
- Vol. 32 (2) , 35-43
Open AccessTreatment and diagnostic algorithm for pregnant women 2–3 trimesters with suspected acute appendicitis
Introduction. Diagnosing the causes of acute abdominal pain in pregnant women is challenging. Due to the absence of ionizing radiation and better visualization of the appendix compared to ultrasound, magnetic resonance imaging is increasingly recommended as an alternative for examining pregnant women with acute abdominal pain. However, in some cases, it is not possible to perform MRI, which limits the use of this method and necessitates stratification of pregnant patients according to the likelihood of adding MRI to the diagnostic complex.The objective was to develop a model for predicting the risk of developing acute appendicitis in pregnant women in the 2nd and 3rd trimesters.Methods and materials. The analysis of data of pregnant patients hospitalized at the Pavlov First Saint Petersburg State Medical University with suspected acute appendicitis was performed from January 2020 to January 2025 (n=94). The study took into account epidemiological, clinical, laboratory, instrumental, surgical and postoperative data. A univariate analysis was performed to predict the presence of acute appendicitis in pregnant women in the 2nd and 3rd trimesters, followed by the construction of a diagnostic model and the identification of risk classes. To confirm the quality of the constructed model, regression analysis was used followed by risk analysis.Results. A model for predicting acute appendicitis in pregnant women in the 2nd–3rd trimesters was constructed based on clinical and laboratory parameters and ultrasound diagnostics with the identification of risk levels (AuRoc 0.84). The patients included in the average risk group underwent MRI to clarify the diagnosis of acute appendicitis and perform differential diagnostics with other pathologies of the abdominal cavity and pelvic organs. The proposed model for predicting acute appendicitis in pregnant women in the 2nd–3rd trimesters using MRI diagnostics in the average risk group has a high predictive quality (AuRoc 0.98) with a sensitivity of 96.9 % and a specificity of 97.6 %.Conclusion. The identified factors (pain in the right lower quadrant of the abdomen, leukocyte level≥12.5·109/l, granulocyte percentage ≥76.4, positive Kocher sign, nausea/vomiting and C-reactive protein level> 6.0 mg/l) can be used to predict acute appendicitis in pregnant women in the 2nd and 3rd trimesters, taking into account the data of instrumental studies (ultrasound and MRI). The constructed model for predicting acute appendicitis, based on clinical and laboratory parameters and ultrasound diagnostics with the identification of risk levels, can be recommended for use in the diagnostics of acute appendicitis in pregnant women in the 2nd and 3rd trimesters. Stratification of pregnant women by the risk level of acute appendicitis allows for the reasonable use of MRI only in the average risk group for the purpose of differential diagnosis of the disease.
- 1 June 2025
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 16 (1) , 35-45
Analyzing results of diagnostics and prediction of acute appendicitis in pregnant women: approaches to solving a well-known clinical problem
BACKGROUND: Currently, despite the development of modern technologies, timely diagnosis of acute appendicitis in pregnant women still remains an important task. Early and correct diagnosis makes it possible to determine the necessary tactics and treatment, which minimizes possible complications and negative results of surgical interventions. AIM: The aim of the study was to analyze medical histories and find a new approach in the diagnosis and treatment of acute appendicitis in pregnant women in the second and third trimesters of pregnancy. MATERIALS AND METHODS: A retrospective analysis of medical records of pregnant patients (n=162) operated on with a diagnosis of acute appendicitis in the period from 2010 to 2019 was carried out. The study took into account epidemiological, clinical, paraclinical, operational and postoperative data. Statistical processing of the obtained data was carried out. RESULTS: When conducting a comparative analysis, the most significant predictors of acute appendicitis in pregnant women were identified: the level of leukocytes in the blood ≥12.5×109/l [relative risk (RR) (confidence interval (CI)) 2.37 (1.47–3.80)], C-reactive protein ≥21.0 mg/l [RR (CI) 1.72 (1.36–2.17)], positive Kocher’s sign [RR (CI) 2.01 (1.50–2.69)], and percentage granulocyte count ≥78.0 [RR (CI) 2.2 (1.29–3.77)], and presence of nausea/vomiting [RR (CI) 1.35 (1.03–1.76)]. Based on the obtained data from univariate analysis, a decision tree diagram was developed to determine the risk of developing acute appendicitis. The proposed decision tree diagram has good sensitivity (65.9%) and specificity (92.1%) with AuROC=0.86. CONCLUSIONS: The constructed diagnostic model can be used in clinical practice to determine the likelihood of acute appendicitis in pregnant women in the II–III trimesters of pregnancy, and the inclusion of magnetic resonance imaging can significantly improve the quality of acute appendicitis diagnosis, which requires further research in this direction.
- 1 June 2025
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 16 (1) , 35-45
Analyzing results of diagnostics and prediction of acute appendicitis in pregnant women: approaches to solving a well-known clinical problem
BACKGROUND: Currently, despite the development of modern technologies, timely diagnosis of acute appendicitis in pregnant women still remains an important task. Early and correct diagnosis makes it possible to determine the necessary tactics and treatment, which minimizes possible complications and negative results of surgical interventions. AIM: The aim of the study was to analyze medical histories and find a new approach in the diagnosis and treatment of acute appendicitis in pregnant women in the second and third trimesters of pregnancy. MATERIALS AND METHODS: A retrospective analysis of medical records of pregnant patients (n=162) operated on with a diagnosis of acute appendicitis in the period from 2010 to 2019 was carried out. The study took into account epidemiological, clinical, paraclinical, operational and postoperative data. Statistical processing of the obtained data was carried out. RESULTS: When conducting a comparative analysis, the most significant predictors of acute appendicitis in pregnant women were identified: the level of leukocytes in the blood ≥12.5×109/l [relative risk (RR) (confidence interval (CI)) 2.37 (1.47–3.80)], C-reactive protein ≥21.0 mg/l [RR (CI) 1.72 (1.36–2.17)], positive Kocher’s sign [RR (CI) 2.01 (1.50–2.69)], and percentage granulocyte count ≥78.0 [RR (CI) 2.2 (1.29–3.77)], and presence of nausea/vomiting [RR (CI) 1.35 (1.03–1.76)]. Based on the obtained data from univariate analysis, a decision tree diagram was developed to determine the risk of developing acute appendicitis. The proposed decision tree diagram has good sensitivity (65.9%) and specificity (92.1%) with AuROC=0.86. CONCLUSIONS: The constructed diagnostic model can be used in clinical practice to determine the likelihood of acute appendicitis in pregnant women in the II–III trimesters of pregnancy, and the inclusion of magnetic resonance imaging can significantly improve the quality of acute appendicitis diagnosis, which requires further research in this direction.
- Open Access
- 1 November 2023
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 69 (5)
Semi-Quantitative Analysis of Mirna-21 in Saliva and Blood Plasma as a Non-Invasive Method for Diagnosing Colorectal Cancer, Lung Cancer and Glial Tumors
Малые некодирующие белок РНК (микроРНК), включая микроРНК-21, в последние годы являются предметом изучения как потенциальные малоинвазивные ранние онкомаркеры. Цель. Оценить уровни экспрессии микроРНК-21 в слюне и плазме крови как метода диагностики колоректального рака (КРР), рака легкого (РЛ) и глиальных церебральных опухолей (ГЦО). Материалы и методы. Уровни экспрессии микроРНК-21 в плазме крови (ПМР-21) и слюне (СМР-21) пациентов с КРР (n = 65), РЛ (n = 14), ГЦО (n = 21) и 66 здоровых добровольцев (КГ) измерены методом полимеразной цепной реакции обратной транскрипции (ОТ-ПЦР) и выражены в условных единицах (УЕ). Для выявления предикторов КРР, РЛ, ГЦО применяли однофакторный анализ. Для формирования рисковых классов наличия онкологического процесса использовали логистическую регрессию. Результаты. СМР-21 (УЕ) при КРР (9,67 ± 18,52), ГЦО (2,51 ± 2,39), РЛ (12,27 ± 14,78) и КГ (1,30 ± 2,45) и ПМР-21 (УЕ) при КРР (3,71 ± 7,38), ГЦО (2,17 ± 2,05), РЛ (8,69 ± 6,76) и КГ (0,84 ± 0,64) статистически значимо (р < 0,001) отличались между собой. СМР-21, но не ПМР-21, при КРР с небольшой глубиной инвазии опухоли (T in situ, T2) был выше, чем при Т4 (р = 0,004; р = 0,042). Этого не наблюдалось у больных с РЛ (СМР-21: р = 0,36; ПМР-21: р = 0,6). Предикторами наличия КРР были возраст > 61 года, СМР-21 ≥ 2,0 УЕ или ПМР-21 ≥ 1,6 УЕ (чувствительность и специфичность — 52 % и 89 %, 61 % и 83 % соответственно). Предикторами для РЛ были: возраст ≥ 54 лет, ПМР-21 ≥ 3,5 УЕ или СМР-21 ≥ 2,5 УЕ (чувствительность и специфичность — 78 % и 64 %, 100 % и 86 % соответственно). У больных ГЦО предикторами были: ПМР-21 ≥ 1,5 УЕ или СМР-21 ≥ 1,6 УЕ (чувствительность и специфичность — 57 % и 71 %, 88 % и 77 % соответственно). Регрессионный анализ прогнозирования наличия онкологического процесса на основе СМР-21 хорошо показал себя при КРР (AuROC = 0,79), в отличии от РЛ (AuROC = 0,70) и ГЦО (AuROC = 0,55). Заключение. СМР-21 является перспективным для диагностики онкологических заболеваний и может быть применен как новый неинвазивный тест при КРР, включая ранние его стадии, и при солидных опухолях других локализаций.
- 1 November 2023
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 69 (5)
Open AccessSemi-Quantitative Analysis of Mirna-21 in Saliva and Blood Plasma as a Non-Invasive Method for Diagnosing Colorectal Cancer, Lung Cancer and Glial Tumors
Малые некодирующие белок РНК (микроРНК), включая микроРНК-21, в последние годы являются предметом изучения как потенциальные малоинвазивные ранние онкомаркеры. Цель. Оценить уровни экспрессии микроРНК-21 в слюне и плазме крови как метода диагностики колоректального рака (КРР), рака легкого (РЛ) и глиальных церебральных опухолей (ГЦО). Материалы и методы. Уровни экспрессии микроРНК-21 в плазме крови (ПМР-21) и слюне (СМР-21) пациентов с КРР (n = 65), РЛ (n = 14), ГЦО (n = 21) и 66 здоровых добровольцев (КГ) измерены методом полимеразной цепной реакции обратной транскрипции (ОТ-ПЦР) и выражены в условных единицах (УЕ). Для выявления предикторов КРР, РЛ, ГЦО применяли однофакторный анализ. Для формирования рисковых классов наличия онкологического процесса использовали логистическую регрессию. Результаты. СМР-21 (УЕ) при КРР (9,67 ± 18,52), ГЦО (2,51 ± 2,39), РЛ (12,27 ± 14,78) и КГ (1,30 ± 2,45) и ПМР-21 (УЕ) при КРР (3,71 ± 7,38), ГЦО (2,17 ± 2,05), РЛ (8,69 ± 6,76) и КГ (0,84 ± 0,64) статистически значимо (р < 0,001) отличались между собой. СМР-21, но не ПМР-21, при КРР с небольшой глубиной инвазии опухоли (T in situ, T2) был выше, чем при Т4 (р = 0,004; р = 0,042). Этого не наблюдалось у больных с РЛ (СМР-21: р = 0,36; ПМР-21: р = 0,6). Предикторами наличия КРР были возраст > 61 года, СМР-21 ≥ 2,0 УЕ или ПМР-21 ≥ 1,6 УЕ (чувствительность и специфичность — 52 % и 89 %, 61 % и 83 % соответственно). Предикторами для РЛ были: возраст ≥ 54 лет, ПМР-21 ≥ 3,5 УЕ или СМР-21 ≥ 2,5 УЕ (чувствительность и специфичность — 78 % и 64 %, 100 % и 86 % соответственно). У больных ГЦО предикторами были: ПМР-21 ≥ 1,5 УЕ или СМР-21 ≥ 1,6 УЕ (чувствительность и специфичность — 57 % и 71 %, 88 % и 77 % соответственно). Регрессионный анализ прогнозирования наличия онкологического процесса на основе СМР-21 хорошо показал себя при КРР (AuROC = 0,79), в отличии от РЛ (AuROC = 0,70) и ГЦО (AuROC = 0,55). Заключение. СМР-21 является перспективным для диагностики онкологических заболеваний и может быть применен как новый неинвазивный тест при КРР, включая ранние его стадии, и при солидных опухолях других локализаций.
- Open Access
- 28 June 2022
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 181 (5) , 83-88
Modern approaches to early diagnosis of CRC
Screening allows detecting not only tumors in the early stages, but also precancerous diseases. Over the past decades, due to the introduction and implementation of screening programs in many Western countries, there has been a gradual decrease in morbidity and mortality. Several screening tests have been developed to detect and prevent colorectal cancer (CRC). These tests differ in technology, cost and object of study. At present, the stool occult blood test and fibrocolonoscopy are mainly used to detect CRC. However, the search for new non-invasive and reliable markers with high sensitivity and specificity and suitable for the early diagnosis of CRC remains an urgent task. Due to the ability of microRNAs to be present outside the formations in various biological fluids of the body and to be determined using the polymerase chain reaction (PCR), the detection of microRNAs has shown significant promise in the diagnosis and prognosis of CRC.
- 28 June 2022
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 181 (5) , 83-88
Open AccessModern approaches to early diagnosis of CRC
Screening allows detecting not only tumors in the early stages, but also precancerous diseases. Over the past decades, due to the introduction and implementation of screening programs in many Western countries, there has been a gradual decrease in morbidity and mortality. Several screening tests have been developed to detect and prevent colorectal cancer (CRC). These tests differ in technology, cost and object of study. At present, the stool occult blood test and fibrocolonoscopy are mainly used to detect CRC. However, the search for new non-invasive and reliable markers with high sensitivity and specificity and suitable for the early diagnosis of CRC remains an urgent task. Due to the ability of microRNAs to be present outside the formations in various biological fluids of the body and to be determined using the polymerase chain reaction (PCR), the detection of microRNAs has shown significant promise in the diagnosis and prognosis of CRC.